Trial
NCT01349036
A Phase 2 Study of PLX3397 in Patients With Recurrent Glioblastoma
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Daiichi Sankyo
Collaborators
Plexxikon
Condition
Recurrent Glioblastoma
Intervention
PLX3397
Why stopped
Business Decision
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-03-03